about
Evaluating linkage to care for hypertension after community-based screening in rural Uganda.Changes in population HIV RNA levels in Mbarara, Uganda, during scale-up of HIV antiretroviral therapy accessClient and provider perspectives of the efficiency and quality of care in the context of rapid scale-up of antiretroviral therapy.Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural UgandaEpidemiology and awareness of hypertension in a rural Ugandan community: a cross-sectional studyUptake of community-based HIV testing during a multi-disease health campaign in rural Uganda.Population-Based Assessment of Hypertension Epidemiology and Risk Factors among HIV-Positive and General Populations in Rural Uganda.Assessment of population-based HIV RNA levels in a rural east African setting using a fingerprick-based blood collection method.A hybrid mobile approach for population-wide HIV testing in rural east Africa: an observational studyCommunity-wide Prevalence of Malaria Parasitemia in HIV-Infected and Uninfected Populations in a High-Transmission Setting in Uganda.Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/μl in rural UgandaImproved employment and education outcomes in households of HIV-infected adults with high CD4 cell counts: evidence from a community health campaign in UgandaImplementation and Operational Research: Cost and Efficiency of a Hybrid Mobile Multidisease Testing Approach With High HIV Testing Coverage in East Africa.High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya.Predictors of Retention in HIV Care Among Youth (15-24) in a Universal Test-and-Treat Setting in Rural Kenya.Population levels and geographical distribution of HIV RNA in rural Ugandan and Kenyan communities, including serodiscordant couples: a cross-sectional analysis.Viral Suppression and Retention in Care up to 5 Years After Initiation of Lifelong ART During Pregnancy (Option B+) in Rural Uganda.Implementation and Operational Research: Population-Based Active Tuberculosis Case Finding During Large-Scale Mobile HIV Testing Campaigns in Rural Uganda.High levels of retention in care with streamlined care and universal test and treat in East Africa.Men "missing" from population-based HIV testing: insights from qualitative research."How can I tell?" Consequences of HIV status disclosure among couples in eastern African communities in the context of an ongoing HIV "test-and-treat" trial.Increased adolescent HIV testing with a hybrid mobile strategy in Uganda and Kenya.Redemption of the "spoiled identity:" the role of HIV-positive individuals in HIV care cascade interventions.Gaps in the Child Tuberculosis Care Cascade in 32 Rural Communities in Uganda and Kenya.Early Adopters of HIV Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda.High CD4 counts associated with better economic outcomes for HIV-positive adults and their HIV-negative household members in the SEARCH Trial.Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the SEARCH StudysMobile, Population-Wide, Hybrid HIV Testing Strategy Increases Number of Children Tested in Rural Kenya and UgandaComparative effectiveness of novel nonmonetary incentives to promote HIV testingHypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH studyDistance to clinic is a barrier to PrEP uptake and visit attendance in a community in rural Uganda
P50
Q33988377-357099E8-264B-4EDE-BB2E-EC5E5FC73D1DQ34231547-F415D5B5-0B20-49AB-9731-239225651A93Q34365296-E62C8DCE-9ED8-457E-99B9-AD4F4B4E014AQ34391572-6C01C9AC-FF40-4235-90EF-C94EAF0394BEQ35062863-6536DFDC-1DAE-4B78-AB4D-82DD6BD85B47Q35083366-8BED9A65-C231-4B26-8193-F390E10A7552Q36032285-0E3CE256-6C29-41A3-9F18-CB44AAD801E1Q36555258-D200657A-EB49-4D92-9F64-FCBF9ADF38A6Q36657618-19B826DD-76E9-4CA1-BC38-6E6716615071Q36931785-8CADD314-6399-4A38-9202-C99354F0C3C0Q36973598-7A55087C-3023-4581-8C3E-B4BBE0F29FC3Q37259148-5F44CACF-B4FF-481A-B9A6-B3E82258BA89Q38376746-6B40D0DE-5E9F-4B3B-9B0E-A958C23012ECQ38849418-7CEE472F-B28A-4DC3-9A12-7437E1CD3F37Q38850636-8771F270-AFB3-4CF5-AD38-3C46B35BB901Q38851830-792C1C1F-448E-4E1F-8C04-0DEAB06141EAQ38852269-87753B2E-840E-4899-A1E4-08E43301E1FCQ38852699-34DC5B06-0E63-4EAC-A104-3E53C79343E8Q38853125-FAEF0CCD-EFCE-4559-87F5-49D0A88F803EQ38853810-9B8DFC05-BFCA-4648-8230-F5F5341255FAQ38853813-43C0CED7-AD1E-4242-A7C6-383D5C9D008FQ38854321-5FCDFB63-B8B1-4E06-A078-EE0738CAED11Q46261962-D71A950F-1138-4F2B-AE39-43D20BF63899Q47227270-3F4F53D4-6771-4627-8CC9-D77A62475751Q54217369-C0CB81E4-9D74-433C-8C01-C560280F4D3CQ55512694-FAF88D47-E935-464D-A9CA-9DCB61442629Q56909157-A0B98E8B-A745-4A60-B283-AA71F9F3954CQ56909575-3741C2E5-CB5A-4C33-BA18-8A4AB2D59389Q56911260-FB46BE1E-FE17-4C7B-B12E-7023A0B9E1DBQ64065117-FA8C66F2-07D7-4AD8-B64F-BFDC0E526766Q64081621-9C157DAE-84BE-4774-B6A6-850179F763F2
P50
name
Dalsone Kwarisiima
@en
Dalsone Kwarisiima
@nl
type
label
Dalsone Kwarisiima
@en
Dalsone Kwarisiima
@nl
prefLabel
Dalsone Kwarisiima
@en
Dalsone Kwarisiima
@nl